Ahead Of Biden-Xi Meeting, Report Encourages U.S., China To Team Up In Cancer Drug Trials
Joint effort would expand trial data available to researchers and help reduce treatment costs, among other benefits, Cure4Cancer says
Stay updated with breaking news from Project Orbis Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Joint effort would expand trial data available to researchers and help reduce treatment costs, among other benefits, Cure4Cancer says
Project Orbis has worked very well for oncology products. CBER Director Dr. Peter Marks has recently started promoting the development of a similar...
Guidance on Project Orbis From: Print this page Project Orbis is a programme coordinated by the US Food and Drug Administration (FDA) to review and approve promising cancer treatments. It involves the regulatory authorities of: Australia (TGA) Brazil (ANVISA) It provides a framework for concurrent submission and review of oncology products among international partners. It aims to deliver faster patient access to innovative cancer treatments with potential benefits over existing therapies across the globe. The MHRA will participate fully in the scheme from 1 January 2021. While the FDA ser...